Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −5.6% | −12.0% | −20.6% | −20.8% | +31.2% | +39.4% | +42.7% | −47.9% | +117.8% | +104.2% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$90 of every $1,000 in ARKG is Tempus
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TEMTempus AI | Healthcare | 9.01% | $901.18 | 2.6M | $156.6M |
| 2 | TWSTTwist Bioscience | Healthcare | 8.57% | $857.42 | 1.3M | $149.0M |
| 3 | TXG10X Genomics | Healthcare | 7.79% | $779.20 | 2.4M | $135.4M |
| 4 | CRSPCrispr Therapeutics AG | Healthcare | 5.33% | $532.54 | 2.4M | $92.5M |
| 5 | GHGuardant Health | Healthcare | 5.19% | $519.44 | 620K | $90.2M |
| 6 | ABSIAbsci | Healthcare | 4.86% | $486.09 | 10.3M | $84.5M |
| 7 | LLYELI Lilly | Healthcare | 4.63% | $462.54 | 59K | $80.4M |
| 8 | ILMNIllumina | Healthcare | 4.61% | $460.74 | 399K | $80.1M |
| 9 | NTRANatera | Healthcare | 4.50% | $449.85 | 270K | $78.2M |
| 10 | SDGRSchrodinger | Technology | 3.50% | $350.26 | 2.3M | $60.9M |
| 11 | BEAMBEAM Therapeutics | Healthcare | 3.47% | $346.53 | 2.9M | $60.2M |
| 12 | CDNACaredx | Healthcare | 3.45% | $345.17 | 834K | $60.0M |
| 13 | ADPTAdaptive Biotechnologies | Healthcare | 2.88% | $288.13 | 1.8M | $50.1M |
| 14 | CMPSCompass Pathways | Healthcare | 2.79% | $279.48 | 5.6M | $48.6M |
| 15 | VCYTVeracyte | Healthcare | 2.54% | $254.06 | 1.8M | $44.1M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TEM | Tempus AI - | 9.01% |
| 2 | TWST | Twist Bioscience | 8.57% |
| 3 | TXG | 10X Genomics - | 7.79% |
| 4 | CRSP | Crispr Therapeutics AG | 5.33% |
| 5 | GH | Guardant Health | 5.19% |
| 6 | ABSI | Absci | 4.86% |
| 7 | LLY | ELI Lilly & | 4.63% |
| 8 | ILMN | Illumina | 4.61% |
| 9 | NTRA | Natera | 4.50% |
| 10 | SDGR | Schrodinger | 3.50% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 29, 2021 | Dec 31, 2021 | $0.38 |
| Dec 29, 2020 | Dec 31, 2020 | $0.79 |
| Dec 27, 2019 | Dec 31, 2019 | $1.05 |
| Dec 27, 2018 | Dec 31, 2018 | $0.47 |
| Dec 27, 2017 | Dec 29, 2017 | $0.33 |